These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

492 related items for PubMed ID: 11552184

  • 1. Prospective assessment of tizanidine for spasticity due to acquired brain injury.
    Meythaler JM, Guin-Renfroe S, Johnson A, Brunner RM.
    Arch Phys Med Rehabil; 2001 Sep; 82(9):1155-63. PubMed ID: 11552184
    [Abstract] [Full Text] [Related]

  • 2. Continuously infused intrathecal baclofen over 12 months for spastic hypertonia in adolescents and adults with cerebral palsy.
    Meythaler JM, Guin-Renfroe S, Law C, Grabb P, Hadley MN.
    Arch Phys Med Rehabil; 2001 Feb; 82(2):155-61. PubMed ID: 11239304
    [Abstract] [Full Text] [Related]

  • 3. Orally delivered baclofen to control spastic hypertonia in acquired brain injury.
    Meythaler JM, Clayton W, Davis LK, Guin-Renfroe S, Brunner RC.
    J Head Trauma Rehabil; 2004 Feb; 19(2):101-8. PubMed ID: 15247821
    [Abstract] [Full Text] [Related]

  • 4. Comparison of clinical and neurophysiologic responses to intrathecal baclofen bolus administration in moderate-to-severe spasticity after acquired brain injury.
    Stokic DS, Yablon SA, Hayes A.
    Arch Phys Med Rehabil; 2005 Sep; 86(9):1801-6. PubMed ID: 16181946
    [Abstract] [Full Text] [Related]

  • 5. Tizanidine treatment of spasticity caused by multiple sclerosis: results of a double-blind, placebo-controlled trial. US Tizanidine Study Group.
    Smith C, Birnbaum G, Carter JL, Greenstein J, Lublin FD.
    Neurology; 1994 Nov; 44(11 Suppl 9):S34-42; discussion S42-3. PubMed ID: 7970009
    [Abstract] [Full Text] [Related]

  • 6. A double-blind, placebo-controlled trial of tizanidine in the treatment of spasticity caused by multiple sclerosis. United Kingdom Tizanidine Trial Group.
    Neurology; 1994 Nov; 44(11 Suppl 9):S70-8. PubMed ID: 7970014
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of tizanidine in the treatment of spasticity in patients with spinal cord injury. North American Tizanidine Study Group.
    Nance PW, Bugaresti J, Shellenberger K, Sheremata W, Martinez-Arizala A.
    Neurology; 1994 Nov; 44(11 Suppl 9):S44-51; discussion S51-2. PubMed ID: 7970010
    [Abstract] [Full Text] [Related]

  • 8. Prospective study on the use of bolus intrathecal baclofen for spastic hypertonia due to acquired brain injury.
    Meythaler JM, DeVivo MJ, Hadley M.
    Arch Phys Med Rehabil; 1996 May; 77(5):461-6. PubMed ID: 8629922
    [Abstract] [Full Text] [Related]

  • 9. Continuously infused intrathecal baclofen for spastic/dystonic hemiplegia: a preliminary report.
    Meythaler JM, Guin-Renfroe S, Hadley MN.
    Am J Phys Med Rehabil; 1999 May; 78(3):247-54. PubMed ID: 10340423
    [Abstract] [Full Text] [Related]

  • 10. A randomized, double-blinded, crossover pilot study assessing the effect of nabilone on spasticity in persons with spinal cord injury.
    Pooyania S, Ethans K, Szturm T, Casey A, Perry D.
    Arch Phys Med Rehabil; 2010 May; 91(5):703-7. PubMed ID: 20434606
    [Abstract] [Full Text] [Related]

  • 11. [The usefulness of tizanidine. A one-year follow-up of the treatment of spasticity in infantile cerebral palsy].
    Vásquez-Briceño A, Arellano-Saldaña ME, León-Hernández SR, Morales-Osorio MG.
    Rev Neurol; 2010 May; 43(3):132-6. PubMed ID: 16871477
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and tolerability of eperisone and baclofen in spastic palsy: a double-blind randomized trial.
    Bresolin N, Zucca C, Pecori A.
    Adv Ther; 2009 May; 26(5):563-73. PubMed ID: 19458926
    [Abstract] [Full Text] [Related]

  • 13. Intrathecal baclofen management of poststroke spastic hypertonia: implications for function and quality of life.
    Ivanhoe CB, Francisco GE, McGuire JR, Subramanian T, Grissom SP.
    Arch Phys Med Rehabil; 2006 Nov; 87(11):1509-15. PubMed ID: 17084128
    [Abstract] [Full Text] [Related]

  • 14. Nightly sublingual tizanidine HCl in multiple sclerosis: clinical efficacy and safety.
    Vakhapova V, Auriel E, Karni A.
    Clin Neuropharmacol; 2010 May; 33(3):151-4. PubMed ID: 20502134
    [Abstract] [Full Text] [Related]

  • 15. Long-term continuously infused intrathecal baclofen for spastic-dystonic hypertonia in traumatic brain injury: 1-year experience.
    Meythaler JM, Guin-Renfroe S, Grabb P, Hadley MN.
    Arch Phys Med Rehabil; 1999 Jan; 80(1):13-9. PubMed ID: 9915366
    [Abstract] [Full Text] [Related]

  • 16. Comparative impact of 2 botulinum toxin injection techniques for elbow flexor hypertonia.
    Mayer NH, Whyte J, Wannstedt G, Ellis CA.
    Arch Phys Med Rehabil; 2008 May; 89(5):982-7. PubMed ID: 18452749
    [Abstract] [Full Text] [Related]

  • 17. Tizanidine treatment of spasticity: a meta-analysis of controlled, double-blind, comparative studies with baclofen and diazepam.
    Groves L, Shellenberger MK, Davis CS.
    Adv Ther; 1998 May; 15(4):241-51. PubMed ID: 10186943
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R.
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [Abstract] [Full Text] [Related]

  • 19. Effect of acupuncture treatment on spastic states of stroke patients.
    Zhao JG, Cao CH, Liu CZ, Han BJ, Zhang J, Li ZG, Yu T, Wang XH, Zhao H, Xu ZH.
    J Neurol Sci; 2009 Jan 15; 276(1-2):143-7. PubMed ID: 18973910
    [Abstract] [Full Text] [Related]

  • 20. Intrathecal baclofen for spastic hypertonia from stroke.
    Meythaler JM, Guin-Renfroe S, Brunner RC, Hadley MN.
    Stroke; 2001 Sep 15; 32(9):2099-109. PubMed ID: 11546903
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.